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Breast cancer is immunogenic and proteins expressed in
breast cancer stimulate both an antibody and a T-cell
immune response. Cancer related proteins that are aber-
rant enough to trigger early immune recognition might be
ideal targets for a vaccine aimed at preventing the develop-
ment of breast cancer. Antigen discovery has focused on
the identification of immunogenic proteins in tumor bear-
ing individuals; in this study we have used SEREX and a
transgenic mouse model to identify immunogenic proteins
in animals prior to the development of cancer. These anti-
gens may represent the earliest alterations of the malig-
nant transformation. We identified 6 antigens that were
present in mice prior to the development of mammary
cancer (Pdhx, Otud6b, Stk39, Zpf238, Lgals8, and Vps35).
These proteins were associated with inflammation,
autoimmunity, and cellular homeostasis, were highly
homologous to human, and were overexpressed in ductal
carcinoma in situ and invasive breast cancer in women.
We questioned whether these antigens could mediate
anti-tumor immunity. When TgMMTV-neu mice (n=5/
group) were vaccinated with the individual antigens, vacci-
nation with Pdhx inhibited tumor growth by 62.1%,
Otud6B inhibited tumor growth by 23.5%, and Stk39
inhibited tumor growth by 50.3% as compared to empty
vector vaccinated control at 27 weeks (p<0.001 for each
individual antigen as compared to empty vector). Sponta-
neous tumorigenesis was inhibited in TgMMTV-neu mice
(n=20 mice/group) vaccinated with a panel of three of the
early tumor antigens (Pdhx, Otud6b, and Stk39). This
panel of antigens inhibited tumor growth by 34.8% by
37 weeks as compared to vector vaccinated mice (p=0.02).
Tumorigenesis was similar to empty vector when animals
were vaccinated with a panel of antigens that were discov-
ered by using sera derived from animals with established
tumors previously identified in our laboratory (Arhgef2,
Swap70, and GSN). At 37 weeks the mice vaccinated with
the established tumor vaccine had similar growth as com-
pared to vector-vaccinated mice (p=0.69) but 31.1% more
growth than the early tumor antigen vaccinated mice
(p=0.005). These data suggest vaccination against a panel
of pre-invasive breast tumor proteins inhibit tumorigenesis
in mice unlike vaccination with a panel of established
tumor proteins, suggesting that these pre-invasive antigens
are better targets for a preventative vaccine. Future studies
will address if these antigens elicit T-cell responses in
patients with high-risk breast lesions.
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